Page last updated: 2024-10-21

phenytoin and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

phenytoin has been researched along with Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome in 1 studies

Research Excerpts

ExcerptRelevanceReference
" Chronic dosing of propranolol may be required for efficacy; therefore, we tested the efficacy of chronic treatment with either propranolol or phenytoin on RTT mice."1.42Treatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs. ( Glaze, DG; Herrera, JA; Kaufmann, WE; Neul, JL; Percy, AK; Pitcher, MR; Skinner, S; Ward, CS; Wehrens, XH, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herrera, JA1
Ward, CS1
Pitcher, MR1
Percy, AK1
Skinner, S1
Kaufmann, WE1
Glaze, DG1
Wehrens, XH1
Neul, JL1

Other Studies

1 other study available for phenytoin and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

ArticleYear
Treatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs.
    Disease models & mechanisms, 2015, Volume: 8, Issue:4

    Topics: Adrenergic beta-Antagonists; Animals; Anticonvulsants; Arrhythmias, Cardiac; Disease Models, Animal;

2015